0
A lab is developing more accurate and powerful liquid biopsy technologies that take advantage of signals from RNA ‘dark matter,’ an understudied area of the genome.
A lab is developing more accurate and powerful liquid biopsy technologies that take advantage of signals from RNA ‘dark matter,’ an understudied area of the genome.